期刊文献+

以壳聚糖为佐剂的幽门螺杆菌疫苗免疫小鼠的TH免疫应答 被引量:2

TH immune response in gastric mucosa by immunization using H.pylori vaccine with chitosan as adjuvant
在线阅读 下载PDF
导出
摘要 目的探讨壳聚糖在幽门螺杆菌疫苗中的免疫佐剂效应.方法将20只Balb/c小鼠分为4组,分别以磷酸盐缓冲液、单纯幽门螺杆菌(Hp)抗原、Hp抗原+壳聚糖酸溶液、Hp抗原+壳聚糖颗粒进行口服免疫,用ELISA法检测胃黏膜中白细胞介素(IL)-2、IL-4,IL-10.结果胃黏膜内IL-10和IL-4的含量在以壳聚糖为佐剂组(255.25,237.05 pg/mg和14.70,14.48 pg/mg)显著高于无佐剂组(104.33和6.49 pg/mg)和对照组(67.13,4.19 pg/mg)(P<0.05~0.01).结论以壳聚糖为佐剂的Hp疫苗可明显促进TH2细胞因子IL-4、IL-10的分泌,这可能在其免疫防御中起作用. Purpose To study the adjuvant effects of chitosan on Helicobacter pylori ( H. pylori ) vaccine. Methods A total of 20 adult mice were divided randomly into four groups. Mice in groups Ⅰ , Ⅱ , Ⅲ and Ⅳ were orally immunized with PBS, H. pylori antigen alone, H. pylori antigen plus chitosan solution, and H. pylori antigen plus chitosan particles, respectively. An ELISA was used to detect IL-2, IL-4, IL-10 levels in gastric mucosa. Results The content of IL-4, IL-10 in gastric mucosa in the groups with chitosan as an adjuvant(255.25,237.05 pg/mg and 14.70,14.48 pg/mg, ) were significantly higher than those in the group without adjuvants( 104.33, 6.49 pg/mg) and control group (67. 13, 4.19 pg/mg, P 〈 0.05-0.01) . Conclusion H. pylori vaccine with chitosan as an adjuvant could significantly promote the secretory of TH2 cytokine (IL-4, IL-10), which might be one of its protective mechanisms.
出处 《中国生化药物杂志》 CAS CSCD 2005年第5期267-269,共3页 Chinese Journal of Biochemical Pharmaceutics
基金 国家自然科学基金资助项目(No.30460052) 江西省学科带头培养项目 江西省卫生厅重点招标项目 江西省教育厅资助项目
关键词 幽门螺杆菌 壳聚糖 疫苗 佐剂 Helicobacter pylori chitosan vaccine adjuvant
  • 相关文献

参考文献12

  • 1Synowiecki J, Al-Khateeb NA. Production, properties, and some new applications of chitin and its derivatives[J]. Crit Rev Food Sci Nutr,2003,43(2): 145-171.
  • 2周南进,谢勇,李弼民,熊远珍,吕农华.壳聚糖抗幽门螺杆菌的实验研究[J].中国生化药物杂志,2003,24(2):71-73. 被引量:18
  • 3Lubben IM,Verhoef JC,Borchard G,et al.Chitosan and its derivatives in mucosal drug and vaccine delivery[J]. Eur J Pharm Sci,2001,14(3) :201-207.
  • 4龚燕锋,谢勇.免疫佐剂与壳聚糖[J].中国生化药物杂志,2004,25(6):374-376. 被引量:7
  • 5Shibata Y, Foster LA, Metzger WJ, et al. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice[J]. Infection and Immunity, 1997,65(5):1734-1741.
  • 6Westerink MA, Smithson SL, Srivastava N, et al. ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid[J]. Vaccine,2001,20(5-6):711-723.
  • 7Mohammadi M, Nedrud J, Redline R, et al. Murine CD4 T-cell response to Helicobacter pylori infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load[J]. Gastroenterology, 1997, 113(6): 1848-1857.
  • 8Borody T, Ren Z, Pang G, et al. Impaired host immunity contributes to Helicobacter pylori eradication failure[J]. Am J Gastroenterol, 2002,97(12):3032-3037.
  • 9Saldinger PF, Porta N, Launois P, et al. Immunization of Balb/c mice with Helicobacter pylori urease B induces a T helper 2 response absent in Helicobacter infection [ J ]. Gastroenterology, 1998, 115(4): 891-897.
  • 10Seferian PG, Martinez ML. Immune stimulating activity of two new chitosan containing adjuvant formulations [ J ]. Vaccine, 2000,19(6):661-668.

二级参考文献28

  • 1Mathivanan N, Kabilan V, Murugesan K. Purification, characterization, and antifungal activity of chitinase from Fusatlum cldamydosporum, a mycoparasile to groundnut rust, Puccinia arachidis[J]. Can J Microbiol, 1998,44(7) :646-651.
  • 2Rhoades J, Holler S. Antimicrobia] actions of degraded and native chitosan against spoilage organisms in laboratory media and foods[ J] . Appl Environ Microbiol, 2000,66( 1 ) :80-86.
  • 3Tsai GJ, Su WH. Antibacterial activity of shrimp chitosan against Escherichia coli[J]. J Food Prot, 1999,62(3) :239-243.
  • 4Tarsi R, Corbin B, Pruzzo C, et al. Effect of low-molecular-weight chitosans on the adhesive properties of oral streptococci[J]. Oral Microbiol Immunol, 1998,13(4) :217-224.
  • 5Marciani DJ. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity[J]. Drug Discov Today, 2003, 8(20):934-943.
  • 6Corsi K, Chellat F, Yahia L, et al. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles [J]. Biomaterials, 2003, 24(7): 1255-1264.
  • 7Romoren K, Thu B J, Evensen O, et al. Immersion delivery of plasmid DNA. Ⅱ . A study of the potentials of a chitosan based delivery system in rainbow trout ( Oncorhynchus mykiss) fry [ J ]. J Control Release,2002, 85(1-3) :215-225.
  • 8Synowiecki J, A1-Khateeb NA. Production, properties, and some new applications of chitin and its derivatives[J]. Crit Rev Food Sci Nutr,2003, 43(2) :145-171.
  • 9Risbud M, Bhonde M, Bhonde R. Chitosan-polyvinyl pyrrolidone hydrogel does not activate macrophages potentials for tranplantation applications[J]. Cell Transplant, 2001, 10(2) :195-202.
  • 10Vord PJ, Matthew HW, Silva SP, et al. Evaluation of the biocompatibility of a chitosan scaffold in mice[J]. J Biomed Mater Res, 2002, 59(3) :585-590.

共引文献23

同被引文献33

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部